Deutsch English Français

Contact

EP3143036

European procedure

Unitary Patent

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3143036

EP3143036 - PAR-1 BASED THERAPEUTIC CONJUGATES AND USES THEREOF [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 07.06.2024 Database last updated on 03.10.2024
Former	The patent has been granted Status updated on 30.06.2023
Former	Grant of patent is intended Status updated on 26.02.2023
Former	Examination is in progress Status updated on 03.03.2020
Former	Request for examination was made Status updated on 17.02.2017
Former	The international publication has been made Status updated on 02.12.2016
Most recent event Tooltip	07.06.2024	No opposition filed within time limit	published on 10.07.2024 [2024/28]
Applicant(s)	For all designated states Tel Hashomer Medical Research Infrastructure and Services Ltd. The Chaim Sheba Medical Center 52621 Ramat Gan / IL
	[2017/12]
Inventor(s)	01 / CHAPMAN, Joab 24 Remez Street 55212 Kiryat Ono / IL
	02 / SHAVIT-STEIN, Efrat 13 Tritch Street 69860 Tel Aviv / IL
	[2017/12]
Representative(s)	Gassner, Birgitta, et al REDL Life Science Patent Attorneys Donau-City-Straße 11 1220 Wien / AT
	[2017/12]
Application number, filing date	15793541.2	11.05.2015
	[2017/12]
	WO2015IL50488
Priority number, date	US201461991532P	11.05.2014 Original published format: US 201461991532 P
	US201562137846P	25.03.2015 Original published format: US 201562137846 P
	[2017/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2015173802
	Date:	19.11.2015
	Language:	EN
	[2015/46]
	Type:	A1 Application with search report
	No.:	EP3143036
	Date:	22.03.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 19.11.2015 takes the place of the publication of the European patent application.
	[2017/12]
	Type:	B1 Patent specification
	No.:	EP3143036
	Date:	02.08.2023
	Language:	EN
	[2023/31]
Search report(s)	International search report - published on:	IL	19.11.2015
	(Supplementary) European search report - dispatched on:	EP	31.01.2018
Classification	IPC:	C07K7/02, C07K5/02, A61K38/04, A61P25/00	[2017/12]
	CPC:	A61K45/06 (EP,US); A61K38/1796 (US); A61K31/519 (EP); A61K38/57 (US); A61K47/54 (EP); A61P25/00 (EP); (+) C07K14/723 (EP,US); C07K5/0806 (EP,US); C07K5/0819 (EP,US); C07K5/101 (EP,US); C07K5/1024 (EP,US); A61K38/00 (EP,US) (-)
	C-Set:	A61K31/519, A61K2300/00 (EP)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/12]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	MA	Not yet paid
Title	German:	PAR-1-BASIERTE THERAPEUTISCHE KONJUGATE UND VERWENDUNGEN DAVON	[2017/12]
	English:	PAR-1 BASED THERAPEUTIC CONJUGATES AND USES THEREOF	[2017/12]
	French:	CONJUGUÉS THÉRAPEUTIQUES À BASE DE PAR-1 ET UTILISATIONS CORRESPONDANTES	[2017/12]
Entry into regional phase	02.12.2016	National basic fee paid
	02.12.2016	Search fee paid
	02.12.2016	Designation fee(s) paid
	02.12.2016	Examination fee paid
Examination procedure	02.12.2016	Examination requested [2017/12]
	02.12.2016	Date on which the examining division has become responsible
	30.07.2018	Amendment by applicant (claims and/or description)
	06.03.2020	Despatch of a communication from the examining division (Time limit: M04)
	06.07.2020	Reply to a communication from the examining division
	27.02.2023	Communication of intention to grant the patent
	23.06.2023	Fee for grant paid
	23.06.2023	Fee for publishing/printing paid
	23.06.2023	Receipt of the translation of the claim(s)
Opposition(s)	03.05.2024	No opposition filed within time limit [2024/28]
Fees paid	Renewal fee
	23.05.2017	Renewal fee patent year 03
	25.05.2018	Renewal fee patent year 04
	23.05.2019	Renewal fee patent year 05
	22.05.2020	Renewal fee patent year 06
	18.05.2021	Renewal fee patent year 07
	25.05.2022	Renewal fee patent year 08
	26.05.2023	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CZ	02.08.2023
	HR	02.08.2023
	PL	02.08.2023
	RO	02.08.2023
	RS	02.08.2023
	SK	02.08.2023
	SM	02.08.2023
	NO	02.11.2023
	GR	03.11.2023
	IS	02.12.2023
	[2024/23]
Former [2024/20]	HR	02.08.2023
	PL	02.08.2023
	RS	02.08.2023
	SM	02.08.2023
	NO	02.11.2023
	GR	03.11.2023
	IS	02.12.2023
Former [2024/10]	HR	02.08.2023
	PL	02.08.2023
	RS	02.08.2023
	NO	02.11.2023
	GR	03.11.2023
	IS	02.12.2023
Former [2024/09]	NO	02.11.2023
	GR	03.11.2023
	IS	02.12.2023
Former [2024/08]	NO	02.11.2023
	GR	03.11.2023
Documents cited:	Search	[I]US4161522 (HAMBURGER ROBERT N [US]) [I] 1-3,5-7,9 * column 5, line 18 - line 41; examples 1, 8b, 10, 11; claims 1, 2 *;
		[A]EP1806141 (KOWA CO [JP]) [A] 1-15 * claims 1-8 *;
		[A]WO2011039584 (TSOPANOGLOU NIKOS [GR], et al) [A] 1-15 * claims 1-3; sequences 1, 4 *;
		[A] - SAMUEL CHACKALAMANNIL, "G-Protein Coupled Receptor Antagonists-1: Protease Activated Receptor-1 (PAR-1) Antagonists as Novel Cardiovascular Therapeutic Agents (Hot Topic: Structure and property Approaches in Recent Drug Discovery Guest Editor: Guo Zhu Zheng)", CURRENT TOPICS IN MEDICINAL CHEMISTRY, (20030501), vol. 3, no. 10, doi:10.2174/1568026033452122, ISSN 1568-0266, pages 1115 - 1123, XP055094137 [A] 1-15 * tables 1, 2 * DOI: http://dx.doi.org/10.2174/1568026033452122
	International search	[A]CA2340461 (UNIV MANITOBA [CA]) [A] 1-20 * paragraph 0032, examples 3 and 4, table 1 *;
		[A]WO02071847 (UNIV EMORY [US], et al) [A] 1-20* FIG. 3, example 2 *;
		[A]WO2011039584 (TSOPANOGLOU NIKOS [GR], et al) [A] 1-20 * SEQ ID NO 4 *;
		[A]WO2013070256 (SCRIPPS RESEARCH INST [US], et al) [A] 1-20 * the whole document, especially paragraph 0062 *;
		[A]WO2013173676 (TUFTS MEDICAL CT INC [US]) [A] 1-20 * table on page 12, page 9 lines 9-20, page 18 lines 6-15 *
	by applicant	US2004092535
		US2007142272
		US2009176803
		US2009281100
		US7842716
		US8232295
		US2012232097
		- SHAVIT et al., Brain, (20080000), vol. 131, no. 4, pages 1113 - 1122
		- SHAVIT et al., J Neurochem., vol. 119, no. 3, pages 460 - 473

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p